Panacea share spurt on govt vaccine order and prequalification prospects
This article was originally published in Scrip
Executive Summary
Shares of India's second-largest vaccines producer, Panacea Biotec, rose on Indian bourses after the company bagged a government order worth more than Rs1.87 billion ($34.4 million) for the supply of 345 million doses of oral polio vaccine.